Recent development of gold (I) and gold (III) complexes as therapeutic agents for cancer diseases

Y Lu, X Ma, X Chang, Z Liang, L Lv, M Shan… - Chemical Society …, 2022 - pubs.rsc.org
Metal complexes have demonstrated significant antitumor activities and platinum complexes
are well established in the clinical application of cancer chemotherapy. However, the …

[HTML][HTML] Advances of medical nanorobots for future cancer treatments

X Kong, P Gao, J Wang, Y Fang, KC Hwang - Journal of Hematology & …, 2023 - Springer
Early detection and diagnosis of many cancers is very challenging. Late stage detection of a
cancer always leads to high mortality rates. It is imperative to develop novel and more …

[HTML][HTML] Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance

Y Wang, Y Chen, J Zhang, Y Yang, JS Fleishman… - Drug Resistance …, 2023 - Elsevier
Cuproptosis is a newly identified form of cell death driven by copper. Recently, the role of
copper and copper triggered cell death in the pathogenesis of cancers have attracted …

[HTML][HTML] Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents

E Domínguez-Álvarez, B Rácz, MA Marć… - Drug Resistance …, 2022 - Elsevier
Selenium is an essential trace element that is crucial for cellular antioxidant defense against
reactive oxygen species (ROS). Recently, many selenium-containing compounds have …

Copper-catalyzed glutathione oxidation is accelerated by the anticancer thiosemicarbazone Dp44mT and further boosted at lower pH

E Falcone, AG Ritacca, S Hager… - Journal of the …, 2022 - ACS Publications
Glutathione (GSH) is the most abundant thiol in mammalian cells and plays a crucial role in
maintaining redox cellular homeostasis. The thiols of two GSH molecules can be oxidized to …

[HTML][HTML] A platinum (IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance

P Fronik, M Gutmann, P Vician, M Stojanovic… - Communications …, 2022 - nature.com
Clinical efficacy of oxaliplatin is frequently limited by severe adverse effects and therapy
resistance. Acquired insensitivity to oxaliplatin is, at least in part, associated with elevated …

Amphiphilic dendrimer doping enhanced pH‐sensitivity of liposomal vesicle for effective Co‐delivery toward synergistic ferroptosis–apoptosis therapy of …

Y Su, Z Zhang, LTO Lee, L Peng, L Lu… - Advanced …, 2023 - Wiley Online Library
Ferroptosis, characterized by the accumulation of reactive oxygen species and lipid
peroxides, has emerged as an attractive strategy to reverse drug resistance. Of particular …

[HTML][HTML] The role of the thioredoxin detoxification system in cancer progression and resistance

M Jovanović, A Podolski-Renić, M Krasavin… - Frontiers in Molecular …, 2022 - frontiersin.org
The intracellular redox homeostasis is a dynamic balancing system between the levels of
free radical species and antioxidant enzymes and small molecules at the core of cellular …

Emerging platinum (IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy

S Zheng, G Li, J Shi, X Liu, M Li, Z He, C Tian… - Journal of Controlled …, 2023 - Elsevier
Owing to the unique DNA damaging cytotoxicity, platinum (Pt)-based chemotherapy has
long been the first-line choice for clinical oncology. Unfortunately, Pt drugs are restricted by …

Synthesis and characterization of polypyridine ruthenium (II) complexes and anticancer efficacy studies in vivo and in vitro

L Liang, X Wu, C Shi, H Wen, S Wu, J Chen… - Journal of Inorganic …, 2022 - Elsevier
In this article, ligand IPP (IPP= 4-(1H-imidazo [4, 5-f][1, 10] phenanthrolin-2-yl)-N, N-
diphenylaniline) and its three Ru (II) complexes:[Ru (bpy) 2 (IPP)](ClO 4) 2 (1)(bpy= 2, 2 …